Causality assessment · Causality: well established

Minoxidil (oral) and Pericardial effusion: is the FAERS signal real?

n=142 co-reports · PRR 2.9 · ROR 2.9

Minoxidil (oral) side-effect profile All assessments See in the full list

A written Bradford Hill assessment of one drug–event pair. The grade is a judgement about the signal, not a statement that this drug causes this event in any one person; FAERS counts are reports, not rates.

Causality: well established

Minoxidil (oral) ↔ Pericardial effusion

n=142 co-reports · PRR 2.9 · ROR 2.9

Oral minoxidil is a potent vasodilator reserved for refractory hypertension, and pericardial effusion is its signature serious adverse effect — seen particularly at higher doses and in patients with renal impairment. The mechanism is thought to involve fluid retention and reflex sympathetic activation, and the effusions can progress to tamponade, which is why the labelling advises caution and monitoring. Low-dose oral minoxidil is now used off-label for hair loss, but the FAERS signal (142 co-reports, PRR 2.9) largely reflects the older antihypertensive use.

Regulatory basis: minoxidil prescribing information (pericardial effusion/tamponade warning; caution in renal impairment).

Bradford Hill viewpoint	Status	Note
Temporality (necessary)	met	Effusion appears during high-dose therapy and resolves after withdrawal
Strength	met	PRR 3 with a modest co-report count
Consistency	met	Reported since the 1970s across antihypertensive use
Specificity	partial	Fairly characteristic of minoxidil among vasodilators
Biological gradient	met	More frequent at higher doses and in renal impairment
Plausibility	met	Fluid retention and reflex sympathetic activation are the proposed mechanisms
Coherence	met	Coheres with the labelled caution and monitoring advice
Experiment	partial	Dechallenge (withdrawal) usually resolves it; no randomized trial
Analogy	met	Analogous to fluid-retention effects of other potent vasodilators

This page's own qualitative read, not an automated/citation-gated assessment.

✗ No ClinicalTrials.gov results-posting trial in the top search hits for minoxidil captured pericardial effusion; the effect is uncommon, dose-related, and identified through post-marketing reports rather than trial AE tables.